article
Falchi L, Nijland M, Huang H, Linton KM, Seymour JF, Tao R, Kwiatek M, Costa A, Vassilakopoulos TP, Greil R, Jiménez-Ubieto A, Gangatharan SA, Benjamini O, Thieblemont C, Tucci A, Elinder-Camburn A, Illes A, Novak J, Pavlovsky MA, McDonald A, Yoon DH, Maruyama D, Sunkersett G, Mei JP, Mukherjee N, Zhu F, Alshreef A, Favaro E, Morschhauser F and
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3…
Lancet
407 (10524), 2026.
article
Trněný M, Fogliatto L, Gardner F, Flinn I, Larouche JF, Haioun C, Canales M, Goto H, Hajek R, Salles G, Singh A, Yan M, Kothari R, Man G, Sahin D, Hirata J, Lee C, Tilly H, Flowers CR
Analysis of peripheral neuropathy in the POLARIX study using clinician- and patient-reported outcomes
Blood Adv
9 (13), 2025.
